Effect of IBD medications on COVID-19 outcomes: results from an international registry

This analysis of SECURE-IBD data (1439 Covid-19 cases; 7.8% severe) found an increased risk of severe Covid-19 with thiopurine (T) monotherapy (adjusted OR 4.08, 95% CI 1.73 to 9.61) and combination anti-TNF and T (4.01, 1.65 to 9.78), when compared to anti-TNF monotherapy.

Gut